SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001080709-21-000008
Filing Date
2021-06-14
Accepted
2021-06-11 17:35:45
Documents
13
Effectiveness Date
2021-06-14

Document Format Files

Seq Description Document Type Size
1 S-8 POS arnas-8pos.htm S-8 POS 140140
2 EX-5.1 ex51s-8poscooleyopinion.htm EX-5.1 14761
3 EX-23.1 ex231consentofkpmg.htm EX-23.1 2188
4 EX-99.5 ex995arenapharmaceuticalsi.htm EX-99.5 149646
5 EX-99.6 ex996arenapharmaceuticalsi.htm EX-99.6 185404
6 EX-99.7 ex997formofnonqualifiedsto.htm EX-99.7 14515
7 EX-99.8 ex998formofrestrictedstock.htm EX-99.8 11670
8 EX-99.9 ex999formofrestrictedstock.htm EX-99.9 11576
9 EX-99.10 ex9910formofnonqualifiedst.htm EX-99.10 14593
10 image_2a.jpg GRAPHIC 369
11 image_3.jpg GRAPHIC 23025
12 image_4.jpg GRAPHIC 8359
13 image_6a.jpg GRAPHIC 237
  Complete submission text file 0001080709-21-000008.txt   589340
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-239330 | Film No.: 211012469
SIC: 2834 Pharmaceutical Preparations